gestalt2 wrote: This is such an important point.
Post# of 148158
This is such an important point. Showing the day 14 reduction in mortality at 82% and then day 28 at 24% says it all. When the leronlimab dosing stopped after 2, the treatment arm became a placebo arm in a way. It is better than just looking at the PE at day 28 because it shows leronlimab was clearly what was working, because as it wore off mortality increased.
my response:
I suppose gestalt2's comment is obvious logic, regardless, I grant him/her the Best Most Important Relevant Comment of The Quarter Award
That's It. That Is Why We Should Get An EUA Today. SP Should Go to $10 Today. We Should Start Shipping LL Tomorrow.